ARG44685

anti-IRF9 antibody

anti-IRF9 antibody for IHC-Formalin-fixed paraffin-embedded sections,Immunoprecipitation,Western blot and Human

Overview

Product Description Mouse Monoclonal antibody recognizes IRF9
Tested Reactivity Hu
Tested Application IHC-P, IP, WB
Host Mouse
Clonality Monoclonal
Isotype IgG1
Target Name IRF9
Antigen Species Human
Conjugation Un-conjugated
Alternate Names ISGF-3 gamma; Transcriptional regulator ISGF3 subunit gamma; ISGF3G; ISGF3; Interferon-stimulated gene factor 3 gamma; IRF-9; ISGF3 p48 subunit; p48; IFN-alpha-responsive transcription factor subunit; Interferon regulatory factor 9

Application Instructions

Application Suggestion
Tested Application Dilution
IHC-P5-10 µg/mL
IP10 µg/mL
WB1 µg/mL
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Protein A purification
Buffer PBS with 0.09% sodium azide
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 10379 Human IRF9

Swiss-port # Q00978 Human Interferon regulatory factor 9

Gene Symbol IRF9
Gene Full Name interferon regulatory factor 9
Background This gene encodes a member of the interferon regulatory factor (IRF) family, a group of transcription factors with diverse roles, including virus-mediated activation of interferon, and modulation of cell growth, differentiation, apoptosis, and immune system activity. Members of the IRF family are characterized by a conserved N-terminal DNA-binding domain containing tryptophan (W) repeats. Mutations in this gene result in Immunodeficiency 65. [provided by RefSeq, Jul 2020]
Function Transcription factor that mediates signaling by type I IFNs (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. IRF9/ISGF3G associates with the phosphorylated STAT1:STAT2 dimer to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state. [UniProt]
Cellular Localization Cytoplasm. Nucleus. Note=Translocated into the nucleus upon activation by IFN-alpha/beta. [UniProt]
Calculated MW 44 kDa
PTM Following recruitment on the activated receptor complex, phosphorylated on Thr-209, probably by IRAK4, resulting in a conformational change of the kinase domain, allowing further phosphorylations to take place. Thr-387 phosphorylation in the activation loop is required to achieve full enzymatic activity.

Polyubiquitinated by TRAF6 after cell stimulation with IL-1-beta by PELI1, PELI2 and PELI3. Polyubiquitination occurs with polyubiquitin chains linked through 'Lys-63'. Ubiquitination promotes interaction with NEMO/IKBKG. Also sumoylated; leading to nuclear translocation. [UniProt]

Images (3) Click the Picture to Zoom In

  • ARG44685 anti-IRF9 antibody IHC-P image

    Immunohistochemistry: Human Lung stained with ARG44685 anti-IRF9 antibody at 5 µg/mL dilution.

  • ARG44685 anti-IRF9 antibody WB image

    Western blot: A431 and THP1 stained with ARG44685 anti-IRF9 antibody at 1 µg/mL dilution.

  • ARG44685 anti-IRF9 antibody IP image

    Immunoprecipitation: THP1 lysate immunoprecipitated with 2.5 µg of ARG44685 anti-IRF9 antibody.